CHDRF yields 2.98% · PFE yields 6.20%● Live data
📍 CHDRF pulled ahead of the other in Year 1
Combined, CHDRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CHDRF + PFE for your $10,000?
Christian Dior SE, through its subsidiaries, engages in the production, distribution, and retail of fashion and leather goods, wines and spirits, perfumes and cosmetics, and watches and jewelry worldwide. The company offers its fashion and leather goods under the Louis Vuitton, Christian Dior Couture, Loewe, Marc Jacobs, Celine, Kenzo, Givenchy, Pink Shirtmaker, Emilio Pucci, Berluti, Loro Piana, Rimowa brand names; wines and spirits under the Hennessy, Glenmorangie, Ardbeg, a Belvedere, Volcán de mi Tierra, Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Château d'Yquem, Ruinart, Belvedere, Glenmorangie, Newton Vineyards, Bodega Numanthia, and Château d'Esclans brand names; and perfumes and cosmetics under the Parfums Christian Dior, Guerlain, Parfums Givenchy, Make Up For Ever, Benefit Cosmetics, Fresh, Acqua di Parma, KVD Vegan Beauty, Fenty, Ole Henriksen, and Maison Francis Kurkdjian brand names. It also provides watches and jewelry under the Tiffany, Bvlgari, TAG Heuer, Zenith, Hublot, Chaumet, and Fred brand names. In addition, the company operates retail stores under the DFS Galleria, Sephora, Le Bon Marché, and Ile de Beauté names; publishes Le Parisien- Aujourd'hui en France, a daily newspaper; designs and builds yachts; and operates the Cova pastry shops. Further, it is involved in real estate activities under the La Samaritaine brand name; and hotel business. The company sells its products through store network, including e-commerce websites; and agents and distributors. As of December 31, 2021, it operated 5,556 stores. The company was incorporated in 1946 and is headquartered in Paris, France. Christian Dior SE was formerly a subsidiary of Semyrhamis SA.
Full CHDRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.